Recombinant incretin-secreting microbe improves metabolic dysfunction in high-fat diet fed rodents
Ryan, Paul M.
Kent, Robert M.
O'Connor, Paula M.
Peterson, Veronica L.
Wishart, David S.
Dinan, Timothy G.
Nature Publishing Group
The gut hormone glucagon-like peptide (GLP)-1 and its analogues represent a new generation of anti-diabetic drugs, which have also demonstrated propensity to modulate host lipid metabolism. Despite this, drugs of this nature are currently limited to intramuscular administration routes due to intestinal degradation. The aim of this study was to design a recombinant microbial delivery vector for a GLP-1 analogue and assess the efficacy of the therapeutic in improving host glucose, lipid and cholesterol metabolism in diet induced obese rodents. Diet-induced obese animals received either Lactobacillus paracasei NFBC 338 transformed to express a long-acting analogue of GLP-1 or the isogenic control microbe which solely harbored the pNZ44 plasmid. Short-term GLP-1 microbe intervention in rats reduced serum low-density lipoprotein cholesterol, triglycerides and triglyceride-rich lipoprotein cholesterol substantially. Conversely, extended GLP-1 microbe intervention improved glucose-dependent insulin secretion, glucose metabolism and cholesterol metabolism, compared to the high-fat control group. Interestingly, the microbe significantly attenuated the adiposity associated with the model and altered the serum lipidome, independently of GLP-1 secretion. These data indicate that recombinant incretin-secreting microbes may offer a novel and safe means of managing cholesterol metabolism and diet induced dyslipidaemia, as well as insulin sensitivity in metabolic dysfunction.
Glucagon-like peptide-1 , Type-2 diabetes-mellitus , Gut microbiota , Lactococcus-lactis , Lipid-metabolism , Healthy humans , Bacteria , Exenatide , GLP-1 , Elevations
Ryan, P. M., Patterson, E., Kent, R. M., Stack, H., O’Connor, P. M., Murphy, K., Peterson, V. L., Mandal, R., Wishart, D. S., Dinan, T. G., Cryan, J. F., Seeley, R. J., Stanton, C. and Ross, R. P. (2017) 'Recombinant incretin-secreting microbe improves metabolic dysfunction in high-fat diet fed rodents', Scientific Reports, 7(1), 13523 (12pp). doi: 10.1038/s41598-017-14010-x
© 2017, the authors. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Te images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.